Literature DB >> 15350704

Modulation of anxiety-related behaviors by mu- and kappa-opioid receptor agonists depends on the social status of mice.

Natalia N Kudryavtseva1, Mirjam A F M Gerrits, Damira F Avgustinovich, Michael V Tenditnik, Jan M Van Ree.   

Abstract

This study was aimed to determine the effects of mu- and kappa-opioid receptor activation in relation to the social status of mice, being a winner with repeated experience of victories or a loser with repeated experience of social defeats. The behaviors of the animals were assessed in a social encounter test measuring the communicative behavior towards a familiar and an unfamiliar partner behind a perforated transparent partition (partition test) and in an elevated plus-maze test estimating the anxiety level of mice. Placebo and graded doses of the mu-opioid receptor agonist DAMGO (0.5 and 2 mg/kg s.c.) and the kappa-opioid receptor agonist U-50,488H (0.6, 1.25, and 2.5 mg/kg s.c.) were administered to the control mice, winners and losers in two experiments. In the partition test, the winners spent somewhat more time and the losers less time than the controls in the vicinity of their partner probably related to a lower and higher level of anxiety respectively. In the plus-maze test the losers appeared to have a somewhat higher anxiety level than the controls and winners. In both tests DAMGO produced anxiogenic-like effects in the winners and the controls, but not in the losers. Winners hardly responded to treatment with U-50,488H, while the losers responded dose dependently with an anxiolytic-like effect in both tests. It is concluded that anxiety-like responses in mice are differentially affected by stimulation of mu- and kappa-opioid receptors and that the effects depend on the social status of the animals.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15350704     DOI: 10.1016/j.peptides.2004.05.005

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  20 in total

Review 1.  30 years of dynorphins--new insights on their functions in neuropsychiatric diseases.

Authors:  Christoph Schwarzer
Journal:  Pharmacol Ther       Date:  2009-05-28       Impact factor: 12.310

Review 2.  The impact of sex as a biological variable in the search for novel antidepressants.

Authors:  Alexia V Williams; Brian C Trainor
Journal:  Front Neuroendocrinol       Date:  2018-05-31       Impact factor: 8.606

3.  The long-term effects of stress and kappa opioid receptor activation on conditioned place aversion in male and female California mice.

Authors:  Abigail R Laman-Maharg; Tiffany Copeland; Evelyn Ordoñes Sanchez; Katharine L Campi; Brian C Trainor
Journal:  Behav Brain Res       Date:  2017-06-15       Impact factor: 3.332

Review 4.  Stress, sex, and motivated behaviors.

Authors:  Abigail Laman-Maharg; Brian C Trainor
Journal:  J Neurosci Res       Date:  2017-01-02       Impact factor: 4.164

5.  The atypical antidepressant mianserin exhibits agonist activity at κ-opioid receptors.

Authors:  Maria C Olianas; Simona Dedoni; Pierluigi Onali
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

6.  Acute inhibition of kappa opioid receptors before stress blocks depression-like behaviors in California mice.

Authors:  Alexia V Williams; Abigail Laman-Maharg; Crystal V Armstrong; Stephanie Ramos-Maciel; Vanessa A Minie; Brian C Trainor
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2018-06-04       Impact factor: 5.067

Review 7.  Strategies for Developing κ Opioid Receptor Agonists for the Treatment of Pain with Fewer Side Effects.

Authors:  Kelly F Paton; Diana V Atigari; Sophia Kaska; Thomas Prisinzano; Bronwyn M Kivell
Journal:  J Pharmacol Exp Ther       Date:  2020-09-10       Impact factor: 4.030

8.  Activation of kappa opioid receptors in the dorsal raphe have sex dependent effects on social behavior in California mice.

Authors:  Emily C Wright; Tiffany V Parks; Jonathon O Alexander; Rajesh Supra; Brian C Trainor
Journal:  Behav Brain Res       Date:  2018-06-07       Impact factor: 3.332

9.  Nicotine anxiogenic and rewarding effects are decreased in mice lacking beta-endorphin.

Authors:  José M Trigo; Andreas Zimmer; Rafael Maldonado
Journal:  Neuropharmacology       Date:  2009-04-17       Impact factor: 5.250

10.  CRF1-R activation of the dynorphin/kappa opioid system in the mouse basolateral amygdala mediates anxiety-like behavior.

Authors:  Michael R Bruchas; Benjamin B Land; Julia C Lemos; Charles Chavkin
Journal:  PLoS One       Date:  2009-12-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.